CSC Heterogeneity in Tumors

Cancer stem cells (CSCs) within a single tumor can exhibit significant phenotypic and functional diversity, contributing to therapeutic resistance and metastasis. This track explores the heterogeneity of CSCs across different cancers and within the same tumor, examining how various CSC subpopulations respond to treatments differently. Researchers investigate how factors such as genetic mutations, epigenetic changes, and microenvironmental influences lead to this diversity. Understanding CSC heterogeneity is essential for developing personalized therapies that can target all CSC subpopulations, preventing relapse and metastasis. This track aims to uncover how CSC heterogeneity drives tumor progression and therapy resistance, offering insights into how tailored interventions could improve patient outcomes.

    Related Conference of CSC Heterogeneity in Tumors

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC Heterogeneity in Tumors Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in